Worth United States has submitted applications for registration of a new herbicidal active ingredient Rapidicil (epyrifenacil) to the US EPA and the Canadian Pest Management Regulatory Agency (PMRA). Rapidicil, the brand name for epyrifenacil, was developed by parent company Valent, Sumitomo Chemical Co., Ltd.
Rapidicil is a new herbicide that is part of a portfolio of products that will be submitted for registration in major markets over the next three years. It belongs to a class of compounds known as protoporphyrinogen oxidase (PPO) inhibitors and can be used to control broadleaf weeds and grasses.
“We are very excited to advance what will be an important new weed control tool for growers in North America,” said Joe Short, director of herbicide strategy, Valent USA “Once approved, Rapidicil will provide growers with a new herbicide with highly effective performance against a wide range of broadleaf weeds and grasses in foliar applications.
Field research has shown Rapidicil to be a fast-acting herbicide that can be used to control weeds in a variety of crops, including corn and soybeans. Rapidicil is also environmentally friendly, contributing to sustainable agriculture as it provides weed control before planting crops in no-till and reduced tillage systems, which can suppress carbon dioxide emissions. carbon compared to conventional tillage practices.
Additionally, Rapidicil is part of a global collaboration between Sumitomo Chemical and Bayer through which it can be used post-planting for post-emergent control of tough weeds like Palmer’s pigweed and water hemp in crops. tolerant to PPO inhibitors currently under development by Bayer. Integrating the knowledge of both companies, this collaboration will provide agricultural producers with effective next-generation solutions to meet their weed control challenges.
Pending regulatory approval, Valent expects the market launch of Rapidicil-based products in the United States and Canada in the middle of this decade.
Valent USA seeks registration of new herbicide Rapidicil